Search company, investor...
Alere company logo

Alere

alere.com

Founded Year

2001

Stage

Acq - P2P | Acquired

Valuation

$0000 

About Alere

Alere delivers information through rapid diagnostic tests. The company focuses on rapid diagnostics for infectious diseases, cardiometabolic diseases and toxicology. The company was founded in 2001 and is based in Waltham, Massachusetts.

Headquarters Location

51 Sawyer Road Suite 200

Waltham, Massachusetts, 02453,

United States

781-647-3900

Missing: Alere's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Alere's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Alere

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Alere is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

3,607 items

Companies that received FDA De Novo clearances since 2010. Companies tagged as #FDADeNovos

H

Health Monitoring & Diagnostics

702 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting

Alere Patents

Alere has filed 159 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • DNA
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/9/2018

5/24/2022

Molecular biology, DNA replication, DNA, Genetics, Biotechnology

Grant

Application Date

10/9/2018

Grant Date

5/24/2022

Title

Related Topics

Molecular biology, DNA replication, DNA, Genetics, Biotechnology

Status

Grant

Latest Alere News

Development of Semi-Automated Urinalysis Market is expected to Booming growth 2023-2030 | Alere, Bio-Rad Lab

Jan 20, 2023

| Alere, Bio-Rad Lab News Provided By Share This Article Urinalysis Market Rising investments for developing home-based urine testing kits is anticipated to propel growth of the global urinalysis market over the forecast period. The global urinalysis market are focused on offering solutions to address data privacy security and compliance concerns. ” — Coherent Market Insights BURLINGAME, CALIFORNIA, UNITED STATES, January 20, 2023 / EINPresswire.com / -- Urinalysis Market , By Product Type (Instruments, Consumables), By Test Type (Macroscopic, Chemistry, Microscopic/Sediment), By Test Testing (Point-of-Care, Laboratory-based), By End User (Hospitals, Independent Laboratories, Physician Practices, Others (Industrial, Institutions, Home Testing, Nursing Facility, etc.)) Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030, The global urinalysis market was valued at US$ 1,483.7 Mn in 2022 and is forecast to reach a value of US$ 1,979.9 Mn by 2027 at a CAGR of 7.2% between 2023 and 2030. Global Urinalysis Market Is Expanding Owing To The Increasing Incidences Of Urinary Tract Infection And Chronic Kidney Diseases Globally Edition : 2023 Scope of Urinalysis For 2023: Urinalysis Market research assesses the rate of growth and market value based on market dynamics and growth generating variables. Complete understanding is based on the most recent industry news, prospects, and trends. The research includes a thorough market analysis and vendor landscape, as well as a SWOT analysis of the top vendors. Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/382 ** Note – This report sample includes: Scope For 2023 Table of Contents (Scope covered as a part of the study) Top players in the market Research framework (structure of the report) Research methodology adopted by Coherent Market Insights Overview: Urinalysis is done as part of a regular medical checkup. Urine testing can also be used for pregnancy testing, drug screenings, and to monitor certain medical conditions. Urinalysis is used to diagnose medical conditions such as kidney disease, urinary tract infections, diabetes, and pregnancy. The test can also be used as part of pre-surgery preparation. Urinalysis is done by collecting a urine sample and sending it to the laboratory for analysis. The test report is then interpreted based on the results of the different components of the test. The report may also include a description of the results from a microscopic examination. A complete urinalysis includes a chemical dipstick test, a microscopic examination, and a visual examination. The test will also check the odor and clarity of the urine. Market Dynamics: Rising investments for developing home-based urine testing kits is anticipated to propel growth of the global urinalysis market over the forecast period. For instance, a funding of USD 6 million was raised by Vivoo in November 2021, for developing at home urine tests. These tests are inexpensive and they provide nutrition and lifestyle guidance. Moreover, unavailability of skilled professionals is estimated to restrain growth of the global urinalysis market over the forecast period. Purchase this Premium Report, click here (Up To 25% Discount) @ Impact of COVID-19: Outbreak of COVID-19 severely impacted the healthcare sector. During the pandemic the healthcare sector was facing huge challenges regarding the availability of skilled healthcare professionals, drugs, medical equipment and medical consumables. This caused immense pressure on the healthcare sector. Hospitals were focusing on treating COVID-19 patients on priority, so many doctors were deployed to attend to these patients. This had a negative impact on patients suffering with other disorders. People suffering with acute kidney injury need to visit a nephrologist regularly and this was not possible due to the strict lockdowns in many regions. This had negative impact on the global urinalysis market. Key Takeaways: The global urinalysis market is estimated to witness significant growth, exhibiting CAGR of 7.2% during the forecast period, due to growing product launches. For instance, qUAntify Advanced Control instrument was launched by Bio-Rad Laboratories, Inc., in January 2022. This instrument is used in monitoring precision urinalysis test procedure and it has increased the effectiveness of statistical processes in a clinical laboratory. North America is estimated to witness significant growth in the global urinalysis market over the forecast period, due to improving healthcare facilities and increasing geriatric population in the region. Key players active in the global urinalysis market are Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Ekf Diagnostics, Abbott, ACON Laboratories, Inc., Quidel Corporation, ARKRAY Inc., Bio-Rad Laboratories, Inc., Trinity Biotech, Sysmex Corporation, Siemens, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Beckman Coulter Inc., Quidel Corporation, and Teco Diagnostics. Enquire for customization in Report @ https://www.coherentmarketinsights.com/insight/request-customization/382 Highlights of the Global Urinalysis report: ‣ A complete backdrop analysis, which includes an assessment of the Urinalysis Market ‣ An objective assessment of the trajectory of the market ‣ Market segmentation up to the second or third level ‣ Reporting and evaluation of recent industry developments ‣ Important changes in market dynamics ‣ Emerging niche segments and regional markets ‣ Historical, current, and projected size of the market from the standpoint of both value and volume ‣ Market shares and strategies of key players ‣ Recommendations to companies for strengthening their foothold in the market The research was compiled based on the synthesis, analysis, and interpretation of data gathered from numerous sources on the parent market. Furthermore, the economic conditions and other economic indicators and determinants have been studied in order to analyse their respective impact on the Urinalysis Market, as well as the current impact, in order to generate strategic and informed forecasts regarding the market scenarios. This is mostly due to the developing world’s unmet potential in terms of product pricing and income creation. Mr.Shah

Alere Frequently Asked Questions (FAQ)

  • When was Alere founded?

    Alere was founded in 2001.

  • Where is Alere's headquarters?

    Alere's headquarters is located at 51 Sawyer Road, Waltham.

  • What is Alere's latest funding round?

    Alere's latest funding round is Acq - P2P.

  • Who are the investors of Alere?

    Investors of Alere include Abbott, Oxford Bioscience Partners, Goldman Sachs, Perry Capital and Galleon Management.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.